Retour aux projets

17673.2 PFLS-LS

Controlled drug delivery to the inner ear using ApidSOL/ApidCOR technology

Résumé

Controlled drug delivery to the inner ear using ApidSOL/ApidCOR technology

Textes supplémentaires

Abstract

Local drug delivery is an important topic for innovative treatments of inner ear diseases, such as hearing loss,|because of increased efficacy and decreased side effects. We propose to use Apidel proprietary drug delivery|technologies to optimize local inner ear administration of an established otoprotective drug (dexamethasone)|and an innovative and otoactive anti NOX3 siRNA. The results are expected to open important market|segments for Apidel.

Participants

Thibault Mugnier

Wirtschaftspartner

thibault.mugnier@apidel.com

Apidel SA Thibault Mugnier Quai du Mont Blanc 29 1201 Genève GE CH

Pascal Senn

Kontaktperson

Pascal.Senn@hcuge.ch

Université de Genève Pascal Senn Rue Michel Servet 1 1211 Genève GE CH

Détails du projet

Office de recherche
INNOSUISSE
Statut du projet
Abgeschlossen
Type de projet
Forschungsprojekt
Date de début
2016-03-31
Date de fin
2018-03-31
Coûts totaux approuvés
CHF 286442.00
Section
20 Förderbereich Life Sciences
Domaine politique NABS
Industrielle Produktivität und Technologie

Disciplines de recherche

  • T490 Biotechnology 100.0%